Literature DB >> 27312879

The in vitro selection world.

Kenan Jijakli1, Basel Khraiwesh1, Weiqi Fu1, Liming Luo2, Amnah Alzahmi1, Joseph Koussa1, Amphun Chaiboonchoe1, Serdal Kirmizialtin3, Laising Yen2, Kourosh Salehi-Ashtiani4.   

Abstract

Through iterative cycles of selection, amplification, and mutagenesis, in vitro selection provides the ability to isolate molecules of desired properties and function from large pools (libraries) of random molecules with as many as 10(16) distinct species. This review, in recognition of a quarter of century of scientific discoveries made through in vitro selection, starts with a brief overview of the method and its history. It further covers recent developments in in vitro selection with a focus on tools that enhance the capabilities of in vitro selection and its expansion from being purely a nucleic acids selection to that of polypeptides and proteins. In addition, we cover how next generation sequencing and modern biological computational tools are being used to complement in vitro selection experiments. On the very least, sequencing and computational tools can translate the large volume of information associated with in vitro selection experiments to manageable, analyzable, and exploitable information. Finally, in vivo selection is briefly compared and contrasted to in vitro selection to highlight the unique capabilities of each method.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  Aptamer; In silico; In vitro selection; In vivo; Next generation sequencing; Phage display; RNA ligands; SELEX

Mesh:

Substances:

Year:  2016        PMID: 27312879     DOI: 10.1016/j.ymeth.2016.06.003

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  13 in total

1.  Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology.

Authors:  Saeideh Foroumadi; Masoumeh Rajabibazl; Azam Rahimpour; Solmaz Shahidi; Walead Ebrahimizadeh; Maral Yarahmadi; Shirin Rajabi; Azam Daraei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-05       Impact factor: 2.416

2.  Multiplex Aptamer Discovery through Apta-Seq and Its Application to ATP Aptamers Derived from Human-Genomic SELEX.

Authors:  Michael M Abdelsayed; Bao T Ho; Michael M K Vu; Julio Polanco; Robert C Spitale; Andrej Lupták
Journal:  ACS Chem Biol       Date:  2017-07-11       Impact factor: 5.100

Review 3.  [Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].

Authors:  Yi-Bin Zhang; Yan-Peng Wang; Jing Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

Review 4.  Aptamers for DNA Damage and Repair.

Authors:  Maureen McKeague
Journal:  Int J Mol Sci       Date:  2017-10-22       Impact factor: 5.923

5.  Refining the Results of a Classical SELEX Experiment by Expanding the Sequence Data Set of an Aptamer Pool Selected for Protein A.

Authors:  Regina Stoltenburg; Beate Strehlitz
Journal:  Int J Mol Sci       Date:  2018-02-24       Impact factor: 5.923

6.  Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.

Authors:  Cristina Romero-López; Thomas Lahlali; Beatriz Berzal-Herranz; Alfredo Berzal-Herranz
Journal:  Molecules       Date:  2017-05-22       Impact factor: 4.411

7.  Targeted evolution of pinning landscapes for large superconducting critical currents.

Authors:  Ivan A Sadovskyy; Alexei E Koshelev; Wai-Kwong Kwok; Ulrich Welp; Andreas Glatz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

8.  SAROTUP: a suite of tools for finding potential target-unrelated peptides from phage display data.

Authors:  Bifang He; Heng Chen; Ning Li; Jian Huang
Journal:  Int J Biol Sci       Date:  2019-06-02       Impact factor: 6.580

9.  In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells.

Authors:  Eman M Hassan; William G Willmore; Bruce C McKay; Maria C DeRosa
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

Review 10.  In silico cancer research towards 3R.

Authors:  Claire Jean-Quartier; Fleur Jeanquartier; Igor Jurisica; Andreas Holzinger
Journal:  BMC Cancer       Date:  2018-04-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.